<P>Contact: Isabelle Uzielli<BR>iuzielli@europcr.com<BR>33-612-233-492<BR>European Society of Cardiology <BR>
<P>21 May 2013, Paris, France: The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent late lumen loss at nine months in the results of an imaging substudy reported at EuroPCR 2013
No comments:
Post a Comment